The prognosis of breast cancer patients with high TLR3 expression is relatively poor, which may be because the activation of TLR3 triggers the β-catenin and NF-κB signaling pathways, which promotes the transformation of breast cancer cells into cancer stem cells [15]. This evidence concerns the gene NFKB1 and breast carcinoma.